We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFGDW
1001
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$99K ﹤0.01%
990,000
BLEUR
1002
DELISTED
bleuacacia ltd Rights
BLEUR
$95K ﹤0.01%
733,333
-366,667
-33% -$47.2K
SLGCW
1003
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$95K ﹤0.01%
125,021
ACQRW
1004
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$95K ﹤0.01%
451,540
SHAP.WS
1005
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$94K ﹤0.01%
787,500
BRD.WS
1006
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$94K ﹤0.01%
625,000
FPAC.WS
1007
DELISTED
Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
FPAC.WS
$93K ﹤0.01%
333,333
PDOT.WS
1008
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$92K ﹤0.01%
510,000
ICNC.WS
1009
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
$83K ﹤0.01%
600,000
SLND.WS icon
1010
Southland Holdings Warrants
SLND.WS
$1.27M
$79K ﹤0.01%
300,000
-600,000
-67% -$200K
DLCAW
1011
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$78K ﹤0.01%
972,234
SCOAW
1012
DELISTED
ScION Tech Growth I Warrant
SCOAW
$76K ﹤0.01%
566,666
NUVB.WS
1013
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$75K ﹤0.01%
266,666
IMPX.WS
1014
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$74K ﹤0.01%
193,700
-297,350
-61% -$179K
XFINW
1015
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$71K ﹤0.01%
375,000
AUS.WS
1016
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$69K ﹤0.01%
250,000
SHUAW
1017
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$68K ﹤0.01%
+450,000
New +$78.2K
RCHGW
1018
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$68K ﹤0.01%
974,485
BLUA.WS
1019
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$67K ﹤0.01%
666,666
SVNAW
1020
DELISTED
7 Acquisition Corp Warrant
SVNAW
$64K ﹤0.01%
400,000
ABLLW
1021
DELISTED
Abacus Life Warrant
ABLLW
$62K ﹤0.01%
280,679
FOXO.WS
1022
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$61K ﹤0.01%
289,659
-310,341
-52% -$78.4K
IPVIW
1023
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$61K ﹤0.01%
244,399
AIRJW
1024
AirJoule Technologies Warrant
AIRJW
$73.3M
$60K ﹤0.01%
300,000
SCOBW
1025
DELISTED
ScION Tech Growth II Warrants
SCOBW
$60K ﹤0.01%
567,947

Similar funds

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.